Zhao, B.-W.; Zhang, F.-Y.; Wang, Y.; Chen, G.-M.; Nie, M.; Zhao, Z.-K.; Chen, X.-J.; Jiang, K.-M.; Nie, R.-C.; Chen, Y.-B.
LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials. Cancers 2022, 14, 4975.
https://doi.org/10.3390/cancers14204975
AMA Style
Zhao B-W, Zhang F-Y, Wang Y, Chen G-M, Nie M, Zhao Z-K, Chen X-J, Jiang K-M, Nie R-C, Chen Y-B.
LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials. Cancers. 2022; 14(20):4975.
https://doi.org/10.3390/cancers14204975
Chicago/Turabian Style
Zhao, Bai-Wei, Fei-Yang Zhang, Yun Wang, Guo-Ming Chen, Man Nie, Zhou-Kai Zhao, Xiao-Jiang Chen, Kai-Ming Jiang, Run-Cong Nie, and Ying-Bo Chen.
2022. "LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials" Cancers 14, no. 20: 4975.
https://doi.org/10.3390/cancers14204975
APA Style
Zhao, B. -W., Zhang, F. -Y., Wang, Y., Chen, G. -M., Nie, M., Zhao, Z. -K., Chen, X. -J., Jiang, K. -M., Nie, R. -C., & Chen, Y. -B.
(2022). LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials. Cancers, 14(20), 4975.
https://doi.org/10.3390/cancers14204975
